ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Abuse Deterrent Formulation Technologies Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-6L1402
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Abuse Deterrent Formulation Technologies Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Abuse Deterrent Formulation Technologies Market Research Report 2025

Code: QYRE-Auto-6L1402
Report
June 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Acura Pharmaceuticals
Altus Formulation
BioDelivery Sciences International
Teva Pharmaceutical
Elysium Therapeutics
Grünenthal
Intellipharmaceutics
Purdue Pharma
Titan pharmaceuticals

Abuse Deterrent Formulation Technologies Market

The global market for Abuse Deterrent Formulation Technologies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Evaluate the general principles of oral solid opioid deterrence deterrence to ensure that there are certain identified anti-abuse measures under the possible routes of abuse to minimize the risk of drug abuse.
North American market for Abuse Deterrent Formulation Technologies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Abuse Deterrent Formulation Technologies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Abuse Deterrent Formulation Technologies in Tablet is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Abuse Deterrent Formulation Technologies include Acura Pharmaceuticals, Altus Formulation, BioDelivery Sciences International, Teva Pharmaceutical, Elysium Therapeutics, Grünenthal, Intellipharmaceutics, Purdue Pharma, TITAN Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Abuse Deterrent Formulation Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Abuse Deterrent Formulation Technologies.
The Abuse Deterrent Formulation Technologies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Abuse Deterrent Formulation Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Abuse Deterrent Formulation Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Abuse Deterrent Formulation Technologies Market Report

Report Metric Details
Report Name Abuse Deterrent Formulation Technologies Market
Segment by Type
  • Antidepressants
  • CNS Stimulants
  • Others
Segment by Application
  • Tablet
  • Capsule
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Acura Pharmaceuticals, Altus Formulation, BioDelivery Sciences International, Teva Pharmaceutical, Elysium Therapeutics, Grünenthal, Intellipharmaceutics, Purdue Pharma, TITAN Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Abuse Deterrent Formulation Technologies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Abuse Deterrent Formulation Technologies Market report?

Ans: The main players in the Abuse Deterrent Formulation Technologies Market are Acura Pharmaceuticals, Altus Formulation, BioDelivery Sciences International, Teva Pharmaceutical, Elysium Therapeutics, Grünenthal, Intellipharmaceutics, Purdue Pharma, TITAN Pharmaceuticals

What are the Application segmentation covered in the Abuse Deterrent Formulation Technologies Market report?

Ans: The Applications covered in the Abuse Deterrent Formulation Technologies Market report are Tablet, Capsule, Other

What are the Type segmentation covered in the Abuse Deterrent Formulation Technologies Market report?

Ans: The Types covered in the Abuse Deterrent Formulation Technologies Market report are Antidepressants, CNS Stimulants, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Abuse Deterrent Formulation Technologies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antidepressants
1.2.3 CNS Stimulants
1.2.4 Others
1.3 Market by Application
1.3.1 Global Abuse Deterrent Formulation Technologies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Abuse Deterrent Formulation Technologies Market Perspective (2020-2031)
2.2 Global Abuse Deterrent Formulation Technologies Growth Trends by Region
2.2.1 Global Abuse Deterrent Formulation Technologies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Abuse Deterrent Formulation Technologies Historic Market Size by Region (2020-2025)
2.2.3 Abuse Deterrent Formulation Technologies Forecasted Market Size by Region (2026-2031)
2.3 Abuse Deterrent Formulation Technologies Market Dynamics
2.3.1 Abuse Deterrent Formulation Technologies Industry Trends
2.3.2 Abuse Deterrent Formulation Technologies Market Drivers
2.3.3 Abuse Deterrent Formulation Technologies Market Challenges
2.3.4 Abuse Deterrent Formulation Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Abuse Deterrent Formulation Technologies Players by Revenue
3.1.1 Global Top Abuse Deterrent Formulation Technologies Players by Revenue (2020-2025)
3.1.2 Global Abuse Deterrent Formulation Technologies Revenue Market Share by Players (2020-2025)
3.2 Global Abuse Deterrent Formulation Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Abuse Deterrent Formulation Technologies Revenue
3.4 Global Abuse Deterrent Formulation Technologies Market Concentration Ratio
3.4.1 Global Abuse Deterrent Formulation Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Abuse Deterrent Formulation Technologies Revenue in 2024
3.5 Global Key Players of Abuse Deterrent Formulation Technologies Head office and Area Served
3.6 Global Key Players of Abuse Deterrent Formulation Technologies, Product and Application
3.7 Global Key Players of Abuse Deterrent Formulation Technologies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Abuse Deterrent Formulation Technologies Breakdown Data by Type
4.1 Global Abuse Deterrent Formulation Technologies Historic Market Size by Type (2020-2025)
4.2 Global Abuse Deterrent Formulation Technologies Forecasted Market Size by Type (2026-2031)
5 Abuse Deterrent Formulation Technologies Breakdown Data by Application
5.1 Global Abuse Deterrent Formulation Technologies Historic Market Size by Application (2020-2025)
5.2 Global Abuse Deterrent Formulation Technologies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Abuse Deterrent Formulation Technologies Market Size (2020-2031)
6.2 North America Abuse Deterrent Formulation Technologies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Abuse Deterrent Formulation Technologies Market Size by Country (2020-2025)
6.4 North America Abuse Deterrent Formulation Technologies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Abuse Deterrent Formulation Technologies Market Size (2020-2031)
7.2 Europe Abuse Deterrent Formulation Technologies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Abuse Deterrent Formulation Technologies Market Size by Country (2020-2025)
7.4 Europe Abuse Deterrent Formulation Technologies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Abuse Deterrent Formulation Technologies Market Size (2020-2031)
8.2 Asia-Pacific Abuse Deterrent Formulation Technologies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Abuse Deterrent Formulation Technologies Market Size by Region (2020-2025)
8.4 Asia-Pacific Abuse Deterrent Formulation Technologies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Abuse Deterrent Formulation Technologies Market Size (2020-2031)
9.2 Latin America Abuse Deterrent Formulation Technologies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Abuse Deterrent Formulation Technologies Market Size by Country (2020-2025)
9.4 Latin America Abuse Deterrent Formulation Technologies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Abuse Deterrent Formulation Technologies Market Size (2020-2031)
10.2 Middle East & Africa Abuse Deterrent Formulation Technologies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Abuse Deterrent Formulation Technologies Market Size by Country (2020-2025)
10.4 Middle East & Africa Abuse Deterrent Formulation Technologies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acura Pharmaceuticals
11.1.1 Acura Pharmaceuticals Company Details
11.1.2 Acura Pharmaceuticals Business Overview
11.1.3 Acura Pharmaceuticals Abuse Deterrent Formulation Technologies Introduction
11.1.4 Acura Pharmaceuticals Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025)
11.1.5 Acura Pharmaceuticals Recent Development
11.2 Altus Formulation
11.2.1 Altus Formulation Company Details
11.2.2 Altus Formulation Business Overview
11.2.3 Altus Formulation Abuse Deterrent Formulation Technologies Introduction
11.2.4 Altus Formulation Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025)
11.2.5 Altus Formulation Recent Development
11.3 BioDelivery Sciences International
11.3.1 BioDelivery Sciences International Company Details
11.3.2 BioDelivery Sciences International Business Overview
11.3.3 BioDelivery Sciences International Abuse Deterrent Formulation Technologies Introduction
11.3.4 BioDelivery Sciences International Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025)
11.3.5 BioDelivery Sciences International Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Abuse Deterrent Formulation Technologies Introduction
11.4.4 Teva Pharmaceutical Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Elysium Therapeutics
11.5.1 Elysium Therapeutics Company Details
11.5.2 Elysium Therapeutics Business Overview
11.5.3 Elysium Therapeutics Abuse Deterrent Formulation Technologies Introduction
11.5.4 Elysium Therapeutics Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025)
11.5.5 Elysium Therapeutics Recent Development
11.6 Grünenthal
11.6.1 Grünenthal Company Details
11.6.2 Grünenthal Business Overview
11.6.3 Grünenthal Abuse Deterrent Formulation Technologies Introduction
11.6.4 Grünenthal Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025)
11.6.5 Grünenthal Recent Development
11.7 Intellipharmaceutics
11.7.1 Intellipharmaceutics Company Details
11.7.2 Intellipharmaceutics Business Overview
11.7.3 Intellipharmaceutics Abuse Deterrent Formulation Technologies Introduction
11.7.4 Intellipharmaceutics Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025)
11.7.5 Intellipharmaceutics Recent Development
11.8 Purdue Pharma
11.8.1 Purdue Pharma Company Details
11.8.2 Purdue Pharma Business Overview
11.8.3 Purdue Pharma Abuse Deterrent Formulation Technologies Introduction
11.8.4 Purdue Pharma Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025)
11.8.5 Purdue Pharma Recent Development
11.9 TITAN Pharmaceuticals
11.9.1 TITAN Pharmaceuticals Company Details
11.9.2 TITAN Pharmaceuticals Business Overview
11.9.3 TITAN Pharmaceuticals Abuse Deterrent Formulation Technologies Introduction
11.9.4 TITAN Pharmaceuticals Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025)
11.9.5 TITAN Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Acura Pharmaceuticals
Altus Formulation
BioDelivery Sciences International
Teva Pharmaceutical
Elysium Therapeutics
Grünenthal
Intellipharmaceutics
Purdue Pharma
Titan pharmaceuticals
List of Tables
 Table 1. Global Abuse Deterrent Formulation Technologies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antidepressants
 Table 3. Key Players of CNS Stimulants
 Table 4. Key Players of Others
 Table 5. Global Abuse Deterrent Formulation Technologies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Abuse Deterrent Formulation Technologies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Abuse Deterrent Formulation Technologies Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Abuse Deterrent Formulation Technologies Market Share by Region (2020-2025)
 Table 9. Global Abuse Deterrent Formulation Technologies Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Abuse Deterrent Formulation Technologies Market Share by Region (2026-2031)
 Table 11. Abuse Deterrent Formulation Technologies Market Trends
 Table 12. Abuse Deterrent Formulation Technologies Market Drivers
 Table 13. Abuse Deterrent Formulation Technologies Market Challenges
 Table 14. Abuse Deterrent Formulation Technologies Market Restraints
 Table 15. Global Abuse Deterrent Formulation Technologies Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Abuse Deterrent Formulation Technologies Market Share by Players (2020-2025)
 Table 17. Global Top Abuse Deterrent Formulation Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Abuse Deterrent Formulation Technologies as of 2024)
 Table 18. Ranking of Global Top Abuse Deterrent Formulation Technologies Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Abuse Deterrent Formulation Technologies Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Abuse Deterrent Formulation Technologies, Headquarters and Area Served
 Table 21. Global Key Players of Abuse Deterrent Formulation Technologies, Product and Application
 Table 22. Global Key Players of Abuse Deterrent Formulation Technologies, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Abuse Deterrent Formulation Technologies Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Abuse Deterrent Formulation Technologies Revenue Market Share by Type (2020-2025)
 Table 26. Global Abuse Deterrent Formulation Technologies Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Abuse Deterrent Formulation Technologies Revenue Market Share by Type (2026-2031)
 Table 28. Global Abuse Deterrent Formulation Technologies Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Abuse Deterrent Formulation Technologies Revenue Market Share by Application (2020-2025)
 Table 30. Global Abuse Deterrent Formulation Technologies Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Abuse Deterrent Formulation Technologies Revenue Market Share by Application (2026-2031)
 Table 32. North America Abuse Deterrent Formulation Technologies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Abuse Deterrent Formulation Technologies Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Abuse Deterrent Formulation Technologies Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Abuse Deterrent Formulation Technologies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Abuse Deterrent Formulation Technologies Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Abuse Deterrent Formulation Technologies Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Abuse Deterrent Formulation Technologies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Abuse Deterrent Formulation Technologies Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Abuse Deterrent Formulation Technologies Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Abuse Deterrent Formulation Technologies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Abuse Deterrent Formulation Technologies Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Abuse Deterrent Formulation Technologies Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Abuse Deterrent Formulation Technologies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Abuse Deterrent Formulation Technologies Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Abuse Deterrent Formulation Technologies Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Acura Pharmaceuticals Company Details
 Table 48. Acura Pharmaceuticals Business Overview
 Table 49. Acura Pharmaceuticals Abuse Deterrent Formulation Technologies Product
 Table 50. Acura Pharmaceuticals Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025) & (US$ Million)
 Table 51. Acura Pharmaceuticals Recent Development
 Table 52. Altus Formulation Company Details
 Table 53. Altus Formulation Business Overview
 Table 54. Altus Formulation Abuse Deterrent Formulation Technologies Product
 Table 55. Altus Formulation Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025) & (US$ Million)
 Table 56. Altus Formulation Recent Development
 Table 57. BioDelivery Sciences International Company Details
 Table 58. BioDelivery Sciences International Business Overview
 Table 59. BioDelivery Sciences International Abuse Deterrent Formulation Technologies Product
 Table 60. BioDelivery Sciences International Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025) & (US$ Million)
 Table 61. BioDelivery Sciences International Recent Development
 Table 62. Teva Pharmaceutical Company Details
 Table 63. Teva Pharmaceutical Business Overview
 Table 64. Teva Pharmaceutical Abuse Deterrent Formulation Technologies Product
 Table 65. Teva Pharmaceutical Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025) & (US$ Million)
 Table 66. Teva Pharmaceutical Recent Development
 Table 67. Elysium Therapeutics Company Details
 Table 68. Elysium Therapeutics Business Overview
 Table 69. Elysium Therapeutics Abuse Deterrent Formulation Technologies Product
 Table 70. Elysium Therapeutics Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025) & (US$ Million)
 Table 71. Elysium Therapeutics Recent Development
 Table 72. Grünenthal Company Details
 Table 73. Grünenthal Business Overview
 Table 74. Grünenthal Abuse Deterrent Formulation Technologies Product
 Table 75. Grünenthal Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025) & (US$ Million)
 Table 76. Grünenthal Recent Development
 Table 77. Intellipharmaceutics Company Details
 Table 78. Intellipharmaceutics Business Overview
 Table 79. Intellipharmaceutics Abuse Deterrent Formulation Technologies Product
 Table 80. Intellipharmaceutics Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025) & (US$ Million)
 Table 81. Intellipharmaceutics Recent Development
 Table 82. Purdue Pharma Company Details
 Table 83. Purdue Pharma Business Overview
 Table 84. Purdue Pharma Abuse Deterrent Formulation Technologies Product
 Table 85. Purdue Pharma Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025) & (US$ Million)
 Table 86. Purdue Pharma Recent Development
 Table 87. TITAN Pharmaceuticals Company Details
 Table 88. TITAN Pharmaceuticals Business Overview
 Table 89. TITAN Pharmaceuticals Abuse Deterrent Formulation Technologies Product
 Table 90. TITAN Pharmaceuticals Revenue in Abuse Deterrent Formulation Technologies Business (2020-2025) & (US$ Million)
 Table 91. TITAN Pharmaceuticals Recent Development
 Table 92. Research Programs/Design for This Report
 Table 93. Key Data Information from Secondary Sources
 Table 94. Key Data Information from Primary Sources
 Table 95. Authors List of This Report


List of Figures
 Figure 1. Abuse Deterrent Formulation Technologies Picture
 Figure 2. Global Abuse Deterrent Formulation Technologies Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Abuse Deterrent Formulation Technologies Market Share by Type: 2024 VS 2031
 Figure 4. Antidepressants Features
 Figure 5. CNS Stimulants Features
 Figure 6. Others Features
 Figure 7. Global Abuse Deterrent Formulation Technologies Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Abuse Deterrent Formulation Technologies Market Share by Application: 2024 VS 2031
 Figure 9. Tablet Case Studies
 Figure 10. Capsule Case Studies
 Figure 11. Other Case Studies
 Figure 12. Abuse Deterrent Formulation Technologies Report Years Considered
 Figure 13. Global Abuse Deterrent Formulation Technologies Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Abuse Deterrent Formulation Technologies Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Abuse Deterrent Formulation Technologies Market Share by Region: 2024 VS 2031
 Figure 16. Global Abuse Deterrent Formulation Technologies Market Share by Players in 2024
 Figure 17. Global Top Abuse Deterrent Formulation Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Abuse Deterrent Formulation Technologies as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Abuse Deterrent Formulation Technologies Revenue in 2024
 Figure 19. North America Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Abuse Deterrent Formulation Technologies Market Share by Country (2020-2031)
 Figure 21. United States Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Abuse Deterrent Formulation Technologies Market Share by Country (2020-2031)
 Figure 25. Germany Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Abuse Deterrent Formulation Technologies Market Share by Region (2020-2031)
 Figure 33. China Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Abuse Deterrent Formulation Technologies Market Share by Country (2020-2031)
 Figure 41. Mexico Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Abuse Deterrent Formulation Technologies Market Share by Country (2020-2031)
 Figure 45. Turkey Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Abuse Deterrent Formulation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Acura Pharmaceuticals Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2020-2025)
 Figure 49. Altus Formulation Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2020-2025)
 Figure 50. BioDelivery Sciences International Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2020-2025)
 Figure 51. Teva Pharmaceutical Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2020-2025)
 Figure 52. Elysium Therapeutics Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2020-2025)
 Figure 53. Grünenthal Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2020-2025)
 Figure 54. Intellipharmaceutics Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2020-2025)
 Figure 55. Purdue Pharma Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2020-2025)
 Figure 56. TITAN Pharmaceuticals Revenue Growth Rate in Abuse Deterrent Formulation Technologies Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Pharmaceutical Excipients for Oral Formulations Market Research Report 2024
Global Oral Controlled Release Drug Delivery Technology Market Research Report 2024
Global Oral Solid Dose Market Research Report 2024
Global Oral Solid Dosage Manufacturing Market Research Report 2025
Global Oral Sustained and Controlled Release Formulations Market Research Report 2025
Global Oral Solid Dosage Pharmaceutical Formulation Market Research Report 2024
Oral Solid Dosage Formulation Development Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Delivery Technology Market Research Report 2024
Global Oral Anesthesia Delivery System Market Research Report 2024
Global Solid Formulations Drug Delivery Market Research Report 2025
Global Oral Analgesics Market Research Report 2024
Global Oral Peptide Drug Market Research Report 2025
Global Acute Agitation and Aggression Treatment Market Insights Forecast to 2030
Global Opioid Analgesics Market Research Report 2025
Global Liquid Formulation Capsule Market Research Report 2025
Global Orally Dissolving Strips Market Research Report 2025
OTC Oral Analgesics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Opioid Dependence Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Solid Chemical Delivery Systems Market Research Report 2024
Global Oral Disintegrating Film Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions